These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 8391440
1. The bis(adenosin-N6-yl)alkanes, a family of potential dinucleoside-polyphosphate analogue precursors. Cytotoxicity, adenosine-receptor binding and metabolism. Chen H, McLennan AG. Eur J Biochem; 1993 Jun 15; 214(3):935-44. PubMed ID: 8391440 [Abstract] [Full Text] [Related]
2. The bis(adenosin-N6-yl) alkanes, a family of potential dinucleoside polyphosphate analogue precursors. Mechanism of growth inhibition and suppression of adenosine toxicity in lymphoid cells. Chen H, McLennan AG. Eur J Biochem; 1993 Jul 15; 215(2):465-71. PubMed ID: 8344314 [Abstract] [Full Text] [Related]
3. Adenosine derivatives with N6-alkyl, -alkylamine or -alkyladenosine substituents as probes for the A1-receptor. van Galen PJ, Ijzerman AP, Soudijn W. FEBS Lett; 1987 Oct 19; 223(1):197-201. PubMed ID: 2959564 [Abstract] [Full Text] [Related]
4. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Bruns RF, Lu GH, Pugsley TA. Mol Pharmacol; 1986 Apr 19; 29(4):331-46. PubMed ID: 3010074 [Abstract] [Full Text] [Related]
5. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals. Pintor J, Díaz-Rey MA, Miras-Portugal MT. Br J Pharmacol; 1993 Apr 19; 108(4):1094-9. PubMed ID: 8485620 [Abstract] [Full Text] [Related]
6. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP, Curtis AR, Kendall DA, Hill SJ. Br J Pharmacol; 1994 Dec 19; 113(4):1501-7. PubMed ID: 7889308 [Abstract] [Full Text] [Related]
7. Identification of A1 and A2 adenosine receptors in the rat spinal cord. Choca JI, Proudfit HK, Green RD. J Pharmacol Exp Ther; 1987 Sep 19; 242(3):905-10. PubMed ID: 3656118 [Abstract] [Full Text] [Related]
9. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors. Olsson RA, Kusachi S, Thompson RD, Ukena D, Padgett W, Daly JW. J Med Chem; 1986 Sep 19; 29(9):1683-9. PubMed ID: 3018244 [Abstract] [Full Text] [Related]
10. Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity. Kaartinen JM, Hreniuk SP, Martin LF, Ranta S, LaNoue KF, Ohisalo JJ. Biochem J; 1991 Oct 01; 279 ( Pt 1)(Pt 1):17-22. PubMed ID: 1656938 [Abstract] [Full Text] [Related]
11. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists. Ukena D, Padgett WL, Hong O, Daly JW, Daly DT, Olsson RA. FEBS Lett; 1987 May 11; 215(2):203-8. PubMed ID: 3582647 [Abstract] [Full Text] [Related]
15. Influence of the molecular structure of N6-(omega-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity. Pirovano IM, IJzerman AP, Van Galen PJ, Soudijn W. Eur J Pharmacol; 1989 May 11; 172(2):185-93. PubMed ID: 2767141 [Abstract] [Full Text] [Related]
16. Diadenosine polyphosphates in insulin-secreting cells: interaction with specific receptors and degradation. Verspohl EJ, Johannwille B. Diabetes; 1998 Nov 11; 47(11):1727-34. PubMed ID: 9792542 [Abstract] [Full Text] [Related]